PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 192 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,903 | +828.3% | 62 | +1140.0% | 0.00% | – |
Q1 2023 | $205 | -99.9% | 5 | -99.9% | 0.00% | -100.0% |
Q1 2018 | $282,000 | +271.1% | 9,050 | +465.6% | 0.00% | – |
Q2 2017 | $76,000 | +4.1% | 1,600 | 0.0% | 0.00% | – |
Q1 2017 | $73,000 | +40.4% | 1,600 | 0.0% | 0.00% | – |
Q4 2016 | $52,000 | -5.5% | 1,600 | 0.0% | 0.00% | – |
Q3 2016 | $55,000 | +1.9% | 1,600 | 0.0% | 0.00% | – |
Q2 2016 | $54,000 | -36.5% | 1,600 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $85,000 | -35.1% | 1,600 | -5.9% | 0.00% | 0.0% |
Q4 2015 | $131,000 | +191.1% | 1,700 | +54.5% | 0.00% | – |
Q3 2015 | $45,000 | -54.1% | 1,100 | 0.0% | 0.00% | -100.0% |
Q1 2015 | $98,000 | +10.1% | 1,100 | +10.0% | 0.00% | 0.0% |
Q4 2014 | $89,000 | -12.7% | 1,000 | -4.8% | 0.00% | 0.0% |
Q3 2014 | $102,000 | +10.9% | 1,050 | +5.0% | 0.00% | 0.0% |
Q2 2014 | $92,000 | +31.4% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $70,000 | -59.5% | 1,000 | -66.7% | 0.00% | -66.7% |
Q4 2013 | $173,000 | +20.1% | 3,002 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $144,000 | +65.5% | 3,002 | 0.0% | 0.00% | +50.0% |
Q2 2013 | $87,000 | – | 3,002 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |